Predictive value of gadoxetic acid-enhanced MRI for posthepatectomy liver failure: a systematic review

Eur Radiol. 2022 Mar;32(3):1792-1803. doi: 10.1007/s00330-021-08297-8. Epub 2021 Sep 25.

Abstract

Objectives: Effective and non-invasive biomarkers to predict and avoid posthepatectomy liver failure (PHLF) are urgently needed. This systematic review aims to evaluate the efficacy of gadoxetic acid-enhanced MRI-derived parameters as an imaging biomarker in preoperative prediction of PHLF.

Methods: A systematic literature search was performed in the databases of PubMed/Medline, Web of Science, Embase, and Cochrane Library up to 11 December 2020. Studies evaluating the incidence of PHLF on patients who underwent hepatectomy with preoperative liver function assessment using gadoxetic acid-enhanced MRI were included. Data was extracted using pre-designed tables. The Quality In Prognostic Studies (QUIPS) tool was adopted to evaluate the risk of bias.

Results: A total of 15 studies were identified for qualitative synthesis and most studies were marked as low to moderate risk of bias in each domain of QUIPS. The most commonly used parameter was relative liver enhancement or its related parameters. The reported incidence of PHLF ranged from 3.9 to 40%. The predictive sensitivity and specificity of gadoxetic acid-enhanced MRI parameters varied from 75 to 100% and from 54 to 93% in ten reported studies. A majority of the studies revealed that the gadoxetic acid-enhanced MRI parameter was a predictor for PHLF.

Conclusions: Gadoxetic acid-enhanced MRI showed a high predictive capacity for PHLF and represents a promising imaging biomarker in prediction of PHLF. Multicenter, prospective trials with large sample size and reliable, unified liver function parameters are required to validate the efficacy of individual liver function parameters.

Key points: • There is an obvious heterogeneity of the published studies, not only in variance of MRI liver function parameters but also in indication and extent of the liver resection. • Signal intensity (SI)-based parameters derived from gadoxetic acid-enhanced MRI are the commonly used method for PHLF prediction. • Gadoxetic acid-enhanced MRI-derived parameters showed high predictive efficacy for PHLF and can potentially serve as a predictor for the incidence of PHLF.

Keywords: Gadolinium ethoxybenzyl DTPA; Hepatectomy; Liver failure; Magnetic resonance imaging; Systematic review.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Contrast Media
  • Gadolinium DTPA
  • Hepatectomy / adverse effects
  • Humans
  • Liver
  • Liver Failure* / diagnostic imaging
  • Liver Failure* / etiology
  • Liver Neoplasms* / diagnostic imaging
  • Liver Neoplasms* / surgery
  • Magnetic Resonance Imaging
  • Multicenter Studies as Topic
  • Postoperative Complications / diagnostic imaging
  • Prospective Studies
  • Retrospective Studies

Substances

  • Contrast Media
  • gadolinium ethoxybenzyl DTPA
  • Gadolinium DTPA